Vertex Pharmaceuticals Incorporated (VRTX) Latest Stock News ...
Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster results from a late-stage clinical trial. Vertex is best known for...
Vertex Pharmaceuticals (VRTX) News Today - MarketBeat
5 days ago · Central Pacific Bank Trust Division cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 40.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,153 shares of the pharmac.
Vertex Pharmaceuticals Incorporated Common Stock (VRTX) - Nasdaq
Discover real-time Vertex Pharmaceuticals Incorporated Common Stock (VRTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.
Vertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance
Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains ... - Nasdaq
1 day ago · Vertex Pharmaceuticals (VRTX) ended the recent trading session at $402.49, demonstrating a -1.13% swing from the preceding day's closing price. This change lagged the S&P 500's daily gain of 0.55%.
Vertex Pharmaceuticals Incorporated Common Stock (VRTX) Real-Time - Nasdaq
Aug 15, 2024 · Get real-time updates on Vertex Pharmaceuticals Incorporated Common Stock (VRTX) stock quotes, trades, and more. Make informed investments with Nasdaq.
Vertex Pharmaceuticals Inc (VRTX) Stock Price & News - Google
Get the latest Vertex Pharmaceuticals Inc (VRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Vertex Pharmaceuticals (VRTX) Stock Price, News & Analysis
2 days ago · Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) posted its quarterly earnings data on Monday, November, 4th. The pharmaceutical company reported $4.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.61 by $0.77.
Vertex Reports Third Quarter 2024 Financial Results | Vertex ...
Nov 4, 2024 · BOSTON--(BUSINESS WIRE)--Nov. 4, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2024, and raised its full-year product revenue guidance to …
VRTX Stock Price | Vertex Pharmaceuticals Inc. Stock Quote (U.S ...
5 days ago · Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to heat up. VRTX |...
- Some results have been removed